Celltrion Pharm, Inc. (KOSDAQ: A068760)
Health Care · Pharmaceuticals · KR
₩42,000.00
-1.87% today · -20.2% 1Y
Celltrion Pharm, Inc. (KOSDAQ: A068760) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.34B.
Over the last twelve months the share price has lost 20.2%, trading between 37.00K and 78.30K.
Tweenvest scores Celltrion Pharm, Inc. across four factors: quality 64/100, value 65/100, growth 100/100. Its strongest factor is growth.
A068760 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.34B
- Revenue (TTM)
- $243.64M
- P/E
- 72.00
- EPS
- 583.36
- Dividend yield
- —
- Beta (5Y)
- 0.92
- 52-week high
- ₩78,300.00
- 52-week low
- ₩37,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 44.21M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,194.90 | -3.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.03 | -1.14% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.57 | -1.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.35 | -0.79% |
Figures last refreshed Aug 18, 2026.